Crossmark

Applications of cell therapy in the treatment of virus-associated cancers

Published Online: 2024-08-19

Published Print: 2024-10

Authors

Toner, Keri

McCann, Chase D.

Bollard, Catherine M. https://orcid.org/0000-0001-5140-9090
License Information

Text and Data Mining valid from 2024-08-19

Version of Record valid from 2024-08-19
More Information

Article History

Accepted: 19 July 2024

First Online: 19 August 2024

Competing interests

: C.M.B. is on the Board of Directors of Cabaletta Bio and is a scientific co-founder and scientific advisory board member of Catamaran Bio, holds stock in Repertoire Immune Medicines and Neximmune, and serves on the data and safety monitoring board of Swedish Orphan Biovitrum (Sobi). The other authors declare no competing interests.

Document is current